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Supplementary Table 1. Full list of contributing authors as part of the International 22q11.2 Brain and Behavior 
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Supplementary Table 2. Detailed grouping criterion for 21 study sites (no. of sample in parentheses) 
Group of study site Study site included 
US and Canada 
CHOP/U. Penn, PA(182); Duke U., Durham, NC(55); Emory U., 
Atlanta, GA(1); Upstate Medical Center, Syracuse, NY(137); 
UCLA, Los Angeles, CA(62); UC Davis, Davis, CA(58); Toronto, 
CA(101) 
Northern Europe Geneva, Switzerland(105); Leuven, Belgium(101); Maastricht, Netherlands(79); Utrecht, Netherlands(130) 
Southern Europe Marseille, France(24); Tel Aviv, Israel(81); Madrid, Spain(25); Mallorca, Spain(14); Rome, Italy(52); Santiago, Chile (60) 
UK and Australia Cardiff, Wales(75); Dublin, Ireland(53); London, England(11); Newcastle, Australia(21),  
 
Supplementary Table 3. Multivariable linear regression analysis of IQ and deletion size with 
adjustment of sex and age stratified by group of study site 
Study site 
  
deletion type (No 
of subjects) 
FSIQ VIQ PIQ 
β P β P β P 
Canada &US  AD (reference,569) 
 
  AB(27) 1.46 0.247 1.77 0.246 1.3 0.363 
Northern Europe AD (reference,392)   
  AB(23) 5.09 1.59E-4 6.13 9.10E-5 4.9 4.24E-4 
Southern Europe AD (reference,238) 
 
  AB(18) 1.64 0.378 0.97 0.649 0.378 0.864 
UK & Australia AD (reference,154) 
 




Supplementary Table 4. Statistical power (%) at 
α=0.05 under various differences in IQ measures 
between 22q11.2DS subjects with AD and AB 
deletions. 









aStandard deviation (SD), PASS software (http://www.ncss.com/pass.html) 
was used for these calculations. In a design of an independent samples t-test, 
we have about 80% power to detect the IQ difference at 0.3 SD level when 
the sample size of AD equals to 1,270 and AB equals to 76, which are close 
to the top two largest deletion groups in our study. 
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Supplementary Table 5. Number of samples with missing values 
for each variable between AD and AB group and the distribution of 
each categorical variable between AD and AB group 
Total number=1427 AD AB P value 
Sex 0.722a 
 Male  647 37  
Female 706 37  
Age 1330 74  
Missing 23 0  
CHDc 0.566a 
Cases 286 17  
Controls 593 30  
Missing 474 26  
FSIQd 1346 74  
Missing 7 0  
VIQe 1150 60  
Missing 203 14  
PIQf 1144 61  
Missing 209 13  
IQ test  0.460b 
Wechsler 1306 73  
Non-Wechsler 39 3  
Unknown  8 1  
Study sites 0.381a 
US&Canada 569 27  
North_Europe 392 23  
South_Europe 238 18  
UK&Australia 154 6  
 aP values were calculated for categorical variables from Pearson chi-square 
software. bP value was calculated from fisher’s exact test, cCHD, congenital 
heart disease, is defined as subjects with Tetralogy of Fallot (TOF), 
Persistent Truncus Arteriosus (PTA) or Interrupted Aortic Arch Type B 

















Supplementary Fig. 2.  IQ differences between subjects with AD and nested A+-D (2.8Mb) 
deletion types. IQ values are expressed as mean±SD. An independent-samples t-test was 
conducted to compare the mean IQ score in subjects carrying the AD deletion with those 
carrying A+-D within the 22q11.2DS cohort.  No significant differences were observed. Numbers 







Supplementary Fig. 3. Distribution of age among subjects with 22q11.2DS with the AD 
deletion and AB deletion, respectively. The distributions of age in both AD (1,351 subjects) and 
AB (77 subjects) groups violate the normal distribution assumption according to the one-sample 
Kolmogorov- Smirnov test (both asymptotic P <0.05), while the distribution is the same between 
AD and AB groups (P>0.05 for Mann-Whitney U test). No significant differences were observed 
for the median ages as indicated by the independent-samples median test (P>0.05). Age is 




Supplementary Fig. 4. Genetic architecture of the 22q11.2 region based on the hg38 genome assembly. 
Coding genes, non-coding genes, miRNA, unknown genes and pseudogenes were aligned along the 3 Mb 
22q11.2 region (chr22:18906222-21451463) spanning the four LCR22s (LCR22A-D), respectively. There are 
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49 coding genes, 18 non-coding RNAs, 7 miRNAs, 3 pseudogenes and 1 gene that is unclear whether it is a 
coding gene or pseudogene. 
 
